We have analyzed the level of Reg-2 and its newly identified targets that encode the cyclins CCND1, CCNE1, CCNE2, CCNB1, CCNA2, and the kinases PLK1 and AURKA in glioma tumors. This evidence concerns the gene PLK1 and central nervous system cancer.